303 related articles for article (PubMed ID: 2286317)
1. [A trial with immunotherapy of ovarian cancer by idiotype vaccination. Activation of the idiotype network in patients with advanced ovarian cancers by treatment with monoclonal antibody OC125].
Wagner U; Reinsberg J; Krebs D
Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):785-8. PubMed ID: 2286317
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
Wagner UA; Oehr PF; Reinsberg J; Schmidt SC; Schlebusch HW; Schultes B; Werner A; Prietl G; Krebs D
Biotechnol Ther; 1992; 3(1-2):81-9. PubMed ID: 1305894
[TBL] [Abstract][Full Text] [Related]
4. Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibody.
Maher VE; Drukman SJ; Kinders RJ; Hunter RE; Jennings J; Brigham C; Stevens S; Griffin TW
J Immunother (1991); 1992 Jan; 11(1):56-66. PubMed ID: 1734949
[TBL] [Abstract][Full Text] [Related]
5. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001.
Wagner U; Köhler S; Reinartz S; Giffels P; Huober J; Renke K; Schlebusch H; Biersack HJ; Möbus V; Kreienberg R; Bauknecht T; Krebs D; Wallwiener D
Clin Cancer Res; 2001 May; 7(5):1154-62. PubMed ID: 11350879
[TBL] [Abstract][Full Text] [Related]
6. [Immune reactions and survival of patients with ovarian carcinomas after administration of 131I-F(Ab)2 fragments of the OC 125 monoclonal antibody].
Schmolling J; Wagner U; Reinsberg J; Biersack HJ; Krebs D
Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):200-3. PubMed ID: 7789708
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic cascades after MAb OC125 application.
Reinsberg J
Hybridoma; 1993 Oct; 12(5):577-82. PubMed ID: 8300133
[No Abstract] [Full Text] [Related]
8. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H
Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546
[TBL] [Abstract][Full Text] [Related]
10. Generation of monoclonal antibodies utilizing the host anti-idiotypic network.
Hatzistilianou MN; Sivolapenko GB; Courtenay-Luck NS; Epenetos AA; Ritter MA
In Vivo; 1995; 9(2):139-44. PubMed ID: 7548789
[TBL] [Abstract][Full Text] [Related]
11. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network.
Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782
[TBL] [Abstract][Full Text] [Related]
12. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR
Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552
[TBL] [Abstract][Full Text] [Related]
13. Construction and expression of a single chain antibody mimicing human ovarian cancer antigen CA125.
Li AD; Li Z; Wang YH; Zhang YM; Ma J
Cell Mol Immunol; 2006 Feb; 3(1):59-62. PubMed ID: 16549051
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.
Raychaudhuri S; Saeki Y; Fuji H; Kohler H
J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue.
Ronay G; Jäger W; Weiss K; Feistel H; Wolf F; Tulusan AH; Lang N
Br J Cancer Suppl; 1990 Jul; 10():67-9. PubMed ID: 2200498
[TBL] [Abstract][Full Text] [Related]
16. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
[TBL] [Abstract][Full Text] [Related]
17. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.
de Moraes JZ; Carneiro CR; Buchegger F; Mach JP; Lopes JD
J Cell Biochem; 1992 Nov; 50(3):324-35. PubMed ID: 1281819
[TBL] [Abstract][Full Text] [Related]
18. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
[TBL] [Abstract][Full Text] [Related]
19. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
Benvenuti F; Burrone OR
Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
[TBL] [Abstract][Full Text] [Related]
20. Immunological responses to the tumor-associated antigen CA125 in patients with advanced ovarian cancer induced by the murine monoclonal anti-idiotype vaccine ACA125.
Wagner U; Schlebusch H; Köhler S; Schmolling J; Grünn U; Krebs D
Hybridoma; 1997 Feb; 16(1):33-40. PubMed ID: 9085126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
